Treatment of New World cutaneous leishmaniasis--a systematic review with a meta-analysis. - Wikidata - wikimedia - TriplyDB

Treatment of New World cutaneous leishmaniasis--a systematic review with a meta-analysis.

Treatment of New World cutaneous leishmaniasis--a systematic review with a meta-analysis.

http://www.wikidata.org/entity/Q33315699

about

Interventions for American cutaneous and mucocutaneous leishmaniasis The Cure Rate after Placebo or No Therapy in American Cutaneous Leishmaniasis: A Systematic Review and Meta-Analysis Treatment of American tegumentary leishmaniasis in special populations: a summary of evidence.Identification of new antileishmanial leads from hits obtained by high-throughput screening Miltefosine and antimonial drug susceptibility of Leishmania Viannia species and populations in regions of high transmission in Colombia Species-specific antimonial sensitivity in Leishmania is driven by post-transcriptional regulation of AQP1 Chemotherapeutic potential of 17-AAG against cutaneous leishmaniasis caused by Leishmania (Viannia) braziliensis Clinical and Parasitological Features of Patients with American Cutaneous Leishmaniasis that Did Not Respond to Treatment with Meglumine Antimoniate DETC induces Leishmania parasite killing in human in vitro and murine in vivo models: a promising therapeutic alternative in Leishmaniasis.Reactivation of mucosal and cutaneous leishmaniasis in a renal transplanted patient.Systemic therapy of New World cutaneous leishmaniasis: A case report and review article.The impact of human immunodeficiency virus (HIV) co-infection on the economic burden of cutaneous leishmaniasis (CL) in Brazil and potential value of new CL drug treatments Update in the treatment of cutaneous leishmaniasis.A species-specific approach to the use of non-antimony treatments for cutaneous leishmaniasis.Novel low-cost thermotherapy for cutaneous leishmaniasis in Peru American tegumentary leishmaniasis and HIV-AIDS association in a tertiary care center in the Brazilian Amazon Efficacy of thermotherapy to treat cutaneous leishmaniasis: a meta-analysis of controlled clinical trials.Noninferiority of miltefosine versus meglumine antimoniate for cutaneous leishmaniasis in children Therapeutic effect of sodium selenite and zinc sulphate as supplementary with meglumine antimoniate( glucantime®) against cutaneous leishmaniasis in BALB/c mice Thermotherapy. An alternative for the treatment of American cutaneous leishmaniasis Old World cutaneous leishmaniasis: diagnosis and treatment The potential economic value of a cutaneous leishmaniasis vaccine in seven endemic countries in the Americas.Intralesional meglumine antimoniate for the treatment of localised cutaneous leishmaniasis: a retrospective review of a Brazilian referral centre Pharmacokinetics of Miltefosine in Children and Adults with Cutaneous Leishmaniasis.Imiquimod in dermatology: an overview.Treatment of imported New World cutaneous leishmaniasis in Germany.Thermotherapy effective and safer than miltefosine in the treatment of cutaneous leishmaniasis in Colombia.Cutaneous leishmaniasis in a returning traveller Efficacy of pentavalent antimoniate intralesional infiltration therapy for cutaneous leishmaniasis: A systematic review.Molecular Identification of Leishmania spp. in Sand Flies (Diptera: Psychodidae, Phlebotominae) From Ecuador.Efficacy of azole therapy for tegumentary leishmaniasis: A systematic review and meta-analysis.Travelers with cutaneous leishmaniasis cured without systemic therapy.Low dose systemic or intralesional meglumine antimoniate treatment for American tegumentary leishmaniasis results in low lethality, low incidence of relapse, and low late mucosal involvement in a referral centre in Rio de Janeiro, Brazil (2001-2013)Cost-effectiveness of liposomal amphotericin B in hospitalised patients with mucocutaneous leishmaniasis.Treatment of cutaneous leishmaniasis with thermotherapy in Brazil: an efficacy and safety study.Meglumine antimoniate intralesional infiltration for localised cutaneous leishmaniasis: a single arm, open label, phase II clinical trial.The Binomial Parasite-Host Immunity in the Healing Process and in Reactivation of Human Tegumentary Leishmaniasis.

P2860

Q24241646-1339905B-44AD-4817-9FB7-3DF7AA33D530 Q26764752-A096440E-BFF4-40A1-B94D-25275FF550CB Q27022964-8A176E42-48DD-4006-8267-00EE1C7EC0B3 Q28481400-CFBAE99E-6DD2-4813-8063-B81F600C4BFA Q28539068-8EAE76AE-37C9-4E25-A0BD-7D610910B4A3 Q28543678-F44B7296-7A99-4CCC-B1C6-FAA7D27E969C Q28544030-78F7C52F-A846-42FF-B8D6-2C05AAA26F06 Q28552530-73282A16-B567-4CC6-9598-4F26F4453B88 Q33784195-59068712-A03B-45F1-A5D2-40488DA930CC Q33841162-2FD82DDB-BF02-474A-9F2C-6E53B517FA53 Q34028355-5197633A-0FAB-40FB-8C15-B0F2B4AE1E9D Q34138468-2AFFC917-1DBE-45DD-8123-38AAA24C7A1A Q34421618-7C2CCCBD-0CBC-488E-8C01-A85533D611EE Q34422191-BD6EE1E0-9EBE-4415-844D-CCB1BF7AA844 Q34713385-2F9BA03D-C997-4E61-BF7B-73E64119531C Q35186855-C3D3D1B8-7B68-4F8B-88E5-6DF87DD996E6 Q35640976-277CA2CB-F135-4129-84C4-1447FE17A42C Q35694752-36678E77-D100-4786-8B71-C3076FC0B3C2 Q35758065-3F47FD39-02FD-4D87-9AF3-42C730E625DA Q36232091-960333BB-3829-417B-A550-61299CD9D837 Q37010084-F7201993-F3B3-43D3-B661-60FC9C3ABC97 Q37147622-DAF707F8-9CE5-43A3-84A1-B2ABB03F4D3B Q37167729-1069D163-FA1C-44D0-8905-DE6C50E9DBEC Q37669845-2AFB341B-91CE-4B3F-8901-1BAD63DFF466 Q38888889-58EEF66C-CE78-4598-924A-4D08FEE0F0AF Q39048632-CFADCD38-478C-452A-83CA-A0CB9351C6CA Q39196755-A835EFC5-9594-4C92-8520-EE11521DF93D Q40668591-2AF43C08-BB5E-4986-864F-C3B583C8D5C3 Q41677439-17380947-E931-4707-9D7F-8164F3681D65 Q41990777-2176D58F-44C4-4E3F-A77B-33E50E7826B3 Q42708364-7DCE3E5D-B418-4694-B3DD-E5974143B253 Q45802306-CE4265D5-479F-4168-AA0F-E726492CCBB9 Q47118269-1803721A-94F8-431F-853F-E63D6EF89715 Q47702322-0E54EE32-61D3-4375-AAF1-91F461484B0E Q55261826-CC17ACE1-B4C4-42E3-A08D-F5AFAF6C8FCF Q55398190-7BE21B1A-9506-4B74-B754-3D1AE175F37E Q55408705-D5B6F0E9-DE76-43B6-A92C-C0CBF744F0C8

P2860

Treatment of New World cutaneous leishmaniasis--a systematic review with a meta-analysis.

http://www.wikidata.org/entity/Q33315699

description

2008 nî lūn-bûn

@nan

2008 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Treatment of New World cutaneous leishmaniasis--a systematic review with a meta-analysis.

@ast

Treatment of New World cutaneous leishmaniasis--a systematic review with a meta-analysis.

@en

Treatment of New World cutaneous leishmaniasis--a systematic review with a meta-analysis.

@nl

type

label

Treatment of New World cutaneous leishmaniasis--a systematic review with a meta-analysis.

@ast

Treatment of New World cutaneous leishmaniasis--a systematic review with a meta-analysis.

@en

Treatment of New World cutaneous leishmaniasis--a systematic review with a meta-analysis.

@nl

prefLabel

Treatment of New World cutaneous leishmaniasis--a systematic review with a meta-analysis.

@ast

Treatment of New World cutaneous leishmaniasis--a systematic review with a meta-analysis.

@en

Treatment of New World cutaneous leishmaniasis--a systematic review with a meta-analysis.

@nl

P1433

Q33315699-E3BE7429-4647-4292-9941-16584997D290

P1476

Q33315699-37B26659-75FC-4CB8-9CC1-0258CDF81650

P2093

Q33315699-07C3F1CC-2914-448D-8D9A-AB19959E2EB1

Q33315699-33C01E5E-99C3-4438-ADB8-CAF08827A6F3

Q33315699-36A92ABA-45A3-4F57-9811-3DB0A3FA85E5

Q33315699-649B5FC7-03F2-409C-89AD-0785152D1910

P2860

Q33315699-0EBB06E3-9D24-47EA-B37A-363F94C05976

Q33315699-2AD2632B-448B-4D2F-9D83-4C451A1F3F95

Q33315699-436976AD-DC14-442E-A1EE-F564AB8DE082

Q33315699-5F0F6BCD-EAB5-47EB-A9C0-8A6803C71FDB

Q33315699-A340657C-884C-47A9-9819-42012C0B1E8E

Q33315699-D4C4A085-0921-434F-BDCC-B755002202DE

Q33315699-EE3765E4-1219-4F29-AE54-9B1463E801A6

Q33315699-F1B10E20-CD2B-4A04-83B5-7FC2962FF332

Q33315699-FBE1861B-D75C-4E98-A2B2-DE7B06ECDD13

P304

Q33315699-A5C2DD93-5F63-492D-88BF-70442AC4B6E7

P31

Q33315699-C04FE781-1A90-4756-A73F-FE15359B9844

Q33315699-c1674e11-0e60-442f-815c-5aa7f7bf1711

P356

Q33315699-C906F796-C6E8-4A9F-A566-97F3F8924A90

P433

Q33315699-8024FE3D-7EDE-4024-9488-378CE4058CAD

P478

Q33315699-5E75E8CC-39EA-4435-9738-B96281E62BBF

P50

Q33315699-B3507F71-F58F-4540-A129-E8BC60A9B34D

Q33315699-B7130FC4-3824-42C6-A7B6-8C966234C118

P577

Q33315699-162362B7-86FF-4CE4-845D-5572AB7029E4

P5875

Q33315699-C1742BAB-2891-4160-B646-71EA276BFAB7

P698

Q33315699-42B1D5A4-E47F-4011-8176-810785072049

P921

Q33315699-CB7BC0E2-A1DB-4689-9229-5670E13D8F60

P356

J.1365-4632.2008.03417.X

P1433

International Journal of Dermatology

P1476

Treatment of New World cutaneous leishmaniasis--a systematic review with a meta-analysis.

@en

P2093

Antonio Carlos Nicodemo

http://www.w3.org/2001/XMLSchema#string

Maria Esther Graf

http://www.w3.org/2001/XMLSchema#string

Valdir Sabbaga Amato

http://www.w3.org/2001/XMLSchema#string

Vicente Amato Neto

http://www.w3.org/2001/XMLSchema#string

P2860

Mutations affecting a yeast mitochondrial inner membrane protein, pnt1p, block export of a mitochondrially synthesized fusion protein from the matrix

Placebo-controlled clinical trial of sodium stibogluconate (Pentostam) versus ketoconazole for treating cutaneous leishmaniasis in Guatemala

Locating and appraising systematic reviews.

Comparative effects of 4-aminopyrazolopyrimidine, its 2'-deoxyriboside derivative, and allopurinol on in vitro growth of American Leishmania species.

[American cutaneous leishmaniasis in the Federal District]

[Mefloquine in the treatment of cutaneous leishmaniasis in an endemic area of Leishmania (Viannia) braziliensis].

[Occurrence of American tegumentary leishmaniasis in the Mato Grosso do Sul State associated to the infection for Leishmania (Leishmania) amazonensis].

Epidemiology of American cutaneous leishmaniasis due to Leishmania braziliensis braziliensis.

[The evaluation of the tolerance and nephrotoxicity of pentavalent antimony administered in a dose of 40 mg Sb V/kg/day, 12/12 hr, for 30 days in the mucocutaneous form of leishmaniasis].

P304

109-124

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1365-4632.2008.03417.X

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

47

http://www.w3.org/2001/XMLSchema#string

P50

Andre M. Siqueira

P577

2008-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

52010403

http://www.w3.org/2001/XMLSchema#string

P698

18211479

http://www.w3.org/2001/XMLSchema#string

P921